136 related articles for article (PubMed ID: 9391566)
1. Anti-human epithelial antigen (Ber-EP4) helps define basal cell carcinoma masked by inflammation.
Kist D; Perkins W; Christ S; Zachary CB
Dermatol Surg; 1997 Nov; 23(11):1067-70. PubMed ID: 9391566
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin.
Tellechea O; Reis JP; Domingues JC; Baptista AP
Am J Dermatopathol; 1993 Oct; 15(5):452-5. PubMed ID: 8238781
[TBL] [Abstract][Full Text] [Related]
3. Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms.
Jimenez FJ; Burchette JL; Grichnik JM; Hitchcock MG
Mod Pathol; 1995 Oct; 8(8):854-8. PubMed ID: 8552575
[TBL] [Abstract][Full Text] [Related]
4. Utility of Ber-EP4 and MOC-31 in Basaloid Skin Tumor Detection.
Gill P; Naugler C; Abi Daoud MS
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):584-588. PubMed ID: 29629953
[TBL] [Abstract][Full Text] [Related]
5. Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma.
Tope WD; Nowfar-Rad M; Kist DA
Dermatol Surg; 2000 May; 26(5):415-8. PubMed ID: 10816226
[TBL] [Abstract][Full Text] [Related]
6. Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms.
Ansai S; Takayama R; Kimura T; Kawana S
J Dermatol; 2012 Aug; 39(8):688-92. PubMed ID: 22300237
[TBL] [Abstract][Full Text] [Related]
7. MOC-31 Antibody Immunolabeling During Mohs Surgery.
Bae E; Saap L; Breen C; Iwamoto S
Dermatol Surg; 2022 Jun; 48(6):595-600. PubMed ID: 35384902
[TBL] [Abstract][Full Text] [Related]
8. [Application of immunohistochemical staining of bcl-2, Ber-EP4, CD10, CK20, and Ki-67 in differential diagnosis between trichoblastoma and basal cell carcinoma].
Zhang ZC; Hu J; Kong YY; Ren M; Cai X
Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):376-381. PubMed ID: 33831998
[No Abstract] [Full Text] [Related]
9. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
11. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
[TBL] [Abstract][Full Text] [Related]
12. Limitations of Ber-EP4 for distinction of Bowen disease from basal cell carcinoma.
Kogut M; Toberer F; Enk AH; Hassel JC
J Cutan Pathol; 2016 Apr; 43(4):367-71. PubMed ID: 26765054
[TBL] [Abstract][Full Text] [Related]
13. Ber-EP4 and MNF-116 in a previously undescribed morphologic pattern of granular basal cell carcinoma.
Hayden AA; Shamma HN
Am J Dermatopathol; 2001 Dec; 23(6):530-2. PubMed ID: 11801795
[TBL] [Abstract][Full Text] [Related]
14. Ber-EP4 antigen is a marker for a cell population related to the secondary hair germ.
Ozawa M; Aiba S; Kurosawa M; Tagami H
Exp Dermatol; 2004 Jul; 13(7):401-5. PubMed ID: 15217359
[TBL] [Abstract][Full Text] [Related]
15. Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery.
Katz KH; Helm KF; Billingsley EM; Maloney ME
J Am Acad Dermatol; 2001 Aug; 45(2):231-8. PubMed ID: 11464184
[TBL] [Abstract][Full Text] [Related]
16. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract][Full Text] [Related]
17. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
18. The immunohistochemical characteristics of the basosquamous cell carcinoma.
Jones MS; Helm KF; Maloney ME
Dermatol Surg; 1997 Mar; 23(3):181-4. PubMed ID: 9145960
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratins as markers of follicular differentiation: an immunohistochemical study of trichoblastoma and basal cell carcinoma.
Kurzen H; Esposito L; Langbein L; Hartschuh W
Am J Dermatopathol; 2001 Dec; 23(6):501-9. PubMed ID: 11801790
[TBL] [Abstract][Full Text] [Related]
20. Sebaceous carcinoma: an immunohistochemical reappraisal.
Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
